OTC Market in Poland 2013: Development forecasts for 2013-2016, New Report Launched

Although the value of the OTC market (medicines and supplements, pharmacy and non-pharmacy sales) remained unchanged in 2012 compared to the situation last year, some crucial changes took place in the sales structure. Due to the higher dynamic of the dietary supplement segment, their growth in the OTC market in 2012 increased by 0.6 p.p.The non-pharmacy sales depend greatly on the existing legislation. The most recent list of substances admitted to trading outside pharmacies was published in October 2010, and it limited the list of such products compared to the previous one. No changes have been introduced since, and generating positive growth rates on the same product group is no longer possible.

Although it was expected that the main beneficiary of the reimbursement act would be the OTC product sector, the new legal regulations have had a significant impact also on the sales of OTC medicines and dietary supplements, particularly in pharmacies. Both the pharmacy and non-pharmacy markets of OTC medicines and dietary supplements therefore observed a zero growth rate in 2012, and reached the value of PLN 8.93bn, almost the same as a year earlier. It turns out that many consumers stocked up also on OTC products at the end of 2011, due to the panic related to the possible price increase expected after the entry of the reimbursement act. As a result, in 2012 – at the beginning of the year in particular – consumers purchased such products to a limited extent. Secondly, the consumers also limited their spending on OTC products that were not basic, as they had to spend more on reimbursed Rx medicines, frequently necessary to save life and limb.

Report Covers:

• The report furnishes data and engages in analysis of these central topicsX
• Buyer attitudes and usage habits with regard to OTC preparations
• OTC products by category, including sales forecasts
• Trends and noteworthy events that can change market conditions
• Manufacturing companies at the forefront of the industry
• Advertising of OTC products in Poland
• Observed OTC switch strategies
• Effects of legal developments and regulations on OTC product development, manufacture, marketing and sales.

Why to Buy This Report?

• Reporting on volatile situations, providing precise evaluations of current conditions and calculating reliable forecasts
• Including the dietary supplements segment in the report for a comprehensive market picture
• Analysing the implications of Poland’s Reimbursement Act (2012) for OTC market growth.

Key Question Answered:

• Which common types of advertising are utilised by companies engaged in OTC manufacturing and sales? What are their typical expenditures?
• Which companies are currently leading the market for OTC products in Poland?
• Why do consumers choose OTC products? How much do they spend and which products do they use on a regular basis?
• How much was the OTC market worth in 2012? What will be its value in 2015?
• What portion of the pharmaceutical market in Poland is occupied by the OTC products segment?
• What are the key categories of OTC products as marketed in Poland?
• What resulting effects will the Reimbursement Act have upon Poland’s OTC products market?

Report Findings:

• In 2011-2012 the number of OTC drugs admitted on the Polish market reached record levels.
• In 2013 the number of flu cases in Poland may reach 3m.
• The Ministry of Health is planning to limit the sales of some OTC medicines.
• In 2013 the Polish OTC market is going to bounce back.
• Dietary supplements will drive the Polish OTC market in 2013-2016.
• Most of the top 10 OTC manufacturers in 2012 observed sales drops in 2012.
• In the first half of 2013 the spending of the pharmaceutical industry on advertising increased by 9% year on year.

Learn about the Polish market for over the counter drugs and dietary supplements available without a prescription in this sixth edition publication.The report closely examines the results of the switch strategy on OTC product sales and updates readers on the assets and performance of the market’s top achievers.It reviews historical data and takes a look at the industry’s future through precise forecasts calculated by Publisher’s team of specialists.Details on market regulation, purchasing habits of OTC product consumers and other influential trends and events combine to provide a comprehensive view of the market’s current status and growth direction.

Spanning over 184 pages, “OTC Market in Poland 2013: Development forecasts for 2013-2016” report covering Methodology, Executive summary, Overview of the OTC market in Poland 2008-2016, Largest manufacturers on the OTC market, Rx-to-OTC and OTC-to-Rx switch strategies, Advertising of OTC products, Consumer behaviour, Legal environment.

Inquiry for more information visit: : http://www.marketresearchreports.com/pmr-ltd/otc-market-poland-2013-development-forecasts-2013-2016

Find All Pharma and Healthcare Reports at : http://www.marketresearchreports.com/pharma-healthcare